검색어 : 통합검색[Tobias Hoheisel]
-
21
-
Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity
-
Nelde, Annika;
Rieth, Jonas;
Roerden, Malte;
Dubbelaar, Marissa L.;
Hoenisch Gravel, Naomi;
Bauer, Jens;
Klein, Reinhild;
Hoheisel, Tobias;
Mahrhofer, Hartmut;
Gö
pel, Siri;
Bitzer, Michael;
Hö
rber, Sebastian;
Peter, Andreas;
Heitmann, Jonas S.;
Walz, Juliane S.;
Department of Peptide-based Immunotherapy, University and University Hospital Tü
bingen, 72076 Tü
bingen, Germany;
Department of Peptide-based Immunotherapy, University and University Hospital Tü
bingen, 72076 Tü
bingen, Germany;
Institute for Cell Biology, Department of Immunology, University of Tü
bingen, 72076 Tü
bingen, Germany;
Department of Peptide-based Immunotherapy, University and University Hospital Tü
bingen, 72076 Tü
bingen, Germany;
Department of Peptide-based Immunotherapy, University and University Hospital Tü
bingen, 72076 Tü
bingen, Germany;
Department of Peptide-based Immunotherapy, University and University Hospital Tü
bingen, 72076 Tü
bingen, Germany;
Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tü
bingen, 72076 Tü
bingen, Germany;
Department of Traumatology and Reconstructive Surgery, BG Trauma Center Tü
bingen, Eberhard Karls University Tü
bingen;
(iscience,
v.25,
2022,
pp.105643)
-
22
-
MediGRID: Towards a user friendly secured grid infrastructure
-
Krefting, Dagmar;
Bart, Julian;
Beronov, Kamen;
Dzhimova, Olga;
Falkner, Jü
rgen;
Hartung, Michael;
Hoheisel, Andreas;
Knoch, Tobias A.;
Lingner, Thomas;
Mohammed, Yassene;
Peter, Kathrin;
Rahm, Erhard;
Sax, Ulrich;
Sommerfeld, Dietmar;
Steinke, Thomas;
Tolxdorff, Thomas;
Vossberg, Michal;
Viezens, Fred;
Weisbecker, Anette;
Institute of Medical Informatics, Charité
- Universitä
tsmedizin Berlin, Germany;
Fraunhofer Institute for Industrial Engineering IAO, Stuttgart, Germany;
Lehrstuhl fü
r Strö
mungsmechanik, Technische Fakultä
t Universitä
t Erlangen, Germany;
Lehrstuhl fü
r Strö
mungsmechanik, Technische Fakultä
t Universitä
t Erlangen, Germany;
Fraunhofer Institute for Industrial Engineering IAO, Stuttgart, Germany;
Interdisciplinary Centre for Bioinformatics, University of Leipzig, Germany;
Fraunhofer Institute for Computer Architecture and Software Technology, Berlin, Germany;
Biophysical Genomics, Kirchhoff Institute for Physics, University of Heidelberg, Germany;
Institute of Microbiology and Genetics, University of Gö
ttingen, Germany;
Universitä
tsmedizin Gö
ttingen, Abteilung Medizinische Informatik, Germany;
Zuse Institute Berlin, Germany;
Department of Computer Science, University of Leipzig, Germany;
Universitä
tsmedizin;
(Future generation computer systems : FGCS,
v.25,
2009,
pp.326-336)
-
23
-
Transcriptional co-factor Transducin beta-like (TBL) 1 acts as a checkpoint in pancreatic cancer malignancy
-
Stoy, Christian;
Sundaram, Aishwarya;
Rios Garcia, Marcos;
Wang, Xiaoyue;
Seibert, Oksana;
Zota, Annika;
Wendler, Susann;
Mä
nnle, David;
Hinz, Ulf;
Sticht, Carsten;
Muciek, Maria;
Gretz, Norbert;
Rose, Adam J;
Greiner, Vera;
Hofmann, Thomas G;
Bauer, Andrea;
Hoheisel, Jö
rg;
Berriel Diaz, Mauricio;
Gaida, Matthias M;
Werner, Jens;
Schafmeier, Tobias;
Strobel, Oliver;
Herzig, Stephan;
Joint Division Molecular Metabolic Control, German Cancer Research Center (DKFZ) Heidelberg, Center for Molecular Biology (ZMBH) and University Hospital, Heidelberg University Heidelberg, Germany;
Joint Division Molecular Metabolic Control, German Cancer Research Center (DKFZ) Heidelberg, Center for Molecular Biology (ZMBH) and University Hospital, Heidelberg University Heidelberg, Germany;
Joint Division Molecular Metabolic Control, German Cancer Research Center (DKFZ) Heidelberg, Center for Molecular Biology (ZMBH) and University Hospital, Heidelberg University Heidelberg, Germany;
Joint Division Molecular Metabolic Control, German Cancer Research Center (DKFZ) Heidelberg, Center for Molecular Biology (ZMBH) and University Hospital, Heidelberg University Heidelberg, Germany;
Joint Division Molecular Metabolic Control, German Cancer Research Center (DKFZ) Heidelberg, Center for Molecular Biology (ZMBH) and University Hospital, Heidelberg University Heidelberg, Germany;
Joint Divi;
(EMBO molecular medicine,
v.7,
2015,
pp.1048-1062)